Patent ID: 11951153
Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITED
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 6:
7. A method of increasing tear production in a subject in need thereof, comprising administering to the subject an ophthalmic aqueous topical formulation consisting of:
0.087-0.093 wt % cyclosporine;
about 1.0 wt % hydrogenated 40 polyoxyl castor oil;
about 0.05 wt % octoxynol-40;
about 0.3 wt % povidone;
about 0.05 wt % sodium chloride;
phosphate buffer, adjusted to a pH of about 5 to about 8 with sodium hydroxide and/or hydrochloric acid; and
water.